Literature DB >> 27245817

[Survival Benefit with Consolidative Radiotherapy in Early-Stage Diffuse Large B‑Cell Lymphoma patients].

Khaled Elsayad1, Hans Theodor Eich2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27245817     DOI: 10.1007/s00066-016-0992-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  14 in total

1.  Radiation therapy improves treatment outcome in patients with diffuse large B-cell lymphoma.

Authors:  Luigi Marcheselli; Raffaella Marcheselli; Alessia Bari; Eliana Valentina Liardo; Fortunato Morabito; Luca Baldini; Maura Brugiatelli; Francesco Merli; Nicola Di Renzo; Stefano Sacchi
Journal:  Leuk Lymphoma       Date:  2011-06-12

2.  Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group.

Authors:  Joachim Yahalom; Tim Illidge; Lena Specht; Richard T Hoppe; Ye-Xiong Li; Richard Tsang; Andrew Wirth
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-05-01       Impact factor: 7.038

3.  Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group.

Authors:  Tim Illidge; Lena Specht; Joachim Yahalom; Berthe Aleman; Anne Kiil Berthelsen; Louis Constine; Bouthaina Dabaja; Kavita Dharmarajan; Andrea Ng; Umberto Ricardi; Andrew Wirth
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-05-01       Impact factor: 7.038

4.  Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial.

Authors:  Lisa Lowry; Paul Smith; Wendi Qian; Stephen Falk; Kim Benstead; Tim Illidge; David Linch; Martin Robinson; Andrew Jack; Peter Hoskin
Journal:  Radiother Oncol       Date:  2011-06-12       Impact factor: 6.280

Review 5.  The Role of Consolidative Radiotherapy after a Complete Response to Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma in the Rituximab Era: Results from a Systematic Review with a Meta-Analysis.

Authors:  Chunhong Hu; Chao Deng; Wen Zou; Guangsen Zhang; Jingjing Wang
Journal:  Acta Haematol       Date:  2015-04-22       Impact factor: 2.195

6.  Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.

Authors:  Jack Phan; Ali Mazloom; L Jeffrey Medeiros; Tony G Zreik; Christine Wogan; Ferial Shihadeh; Maria Alma Rodriguez; Luis Fayad; Nathan Fowler; Valerie Reed; Patrecia Horace; Bouthaina Shbib Dabaja
Journal:  J Clin Oncol       Date:  2010-08-16       Impact factor: 44.544

7.  Cardiac mortality in patients with stage I and II diffuse large B-cell lymphoma treated with and without radiation: a surveillance, epidemiology, and end-results analysis.

Authors:  Thomas J Pugh; Ari Ballonoff; Kyle E Rusthoven; Robert McCammon; Brian Kavanagh; Francis Newman; Rachel Rabinovitch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-08       Impact factor: 7.038

8.  Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.

Authors:  Michael Pfreundschuh; Anthony D Ho; Eva Cavallin-Stahl; Max Wolf; Ruth Pettengell; Ingrid Vasova; Andrew Belch; Jan Walewski; Pier-Luigi Zinzani; Walter Mingrone; Stein Kvaloy; Ofer Shpilberg; Ulrich Jaeger; Mads Hansen; Claudia Corrado; Adriana Scheliga; Markus Loeffler; Evelyn Kuhnt
Journal:  Lancet Oncol       Date:  2008-04-08       Impact factor: 41.316

9.  Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis.

Authors:  Ari Ballonoff; Kyle E Rusthoven; Amanda Schwer; Robert McCammon; Brian Kavanagh; Michael Bassetti; Francis Newman; Rachel Rabinovitch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-19       Impact factor: 7.038

10.  Impact of rituximab and radiotherapy on outcome of patients with aggressive B-cell lymphoma and skeletal involvement.

Authors:  Gerhard Held; Samira Zeynalova; Niels Murawski; Marita Ziepert; Barbara Kempf; Andreas Viardot; Martin Dreyling; Michael Hallek; Mathias Witzens-Harig; Jochen Fleckenstein; Christian Rübe; Carsten Zwick; Bertram Glass; Norbert Schmitz; Michael Pfreundschuh
Journal:  J Clin Oncol       Date:  2013-09-23       Impact factor: 44.544

View more
  1 in total

Review 1.  Post-transplant lymphoproliferative disorder in the pelvis successfully treated with consolidative radiotherapy.

Authors:  Omar Habibeh; Khaled Elsayad; Jan Kriz; Uwe Haverkamp; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2016-06-22       Impact factor: 3.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.